| 25A683 |
Monsanto Company v. Daniel Anderson, et al. |
Missouri |
2025-12-10 |
Application |
|
cancer-warning failure-to-warn fifra-preemption glyphosate pesticide-labeling punitive-damages |
Question not identified. |
| 24-1098 |
Monsanto Company v. Larry Johnson, et al. |
Oregon |
2025-04-22 |
Pending |
Relisted (3) |
epa-regulation failure-to-warn fifra-preemption product-liability state-law warning-requirements |
Whether FIFRA preempts a state-law failure-to-warn claim where EPA has repeatedly concluded that the warning is not required and the warning cannot be… |
| 24-1097 |
Monsanto Company, a Foreign Corporation v. Nancy C. Salas |
Eleventh Circuit |
2025-04-22 |
Pending |
Relisted (3) |
epa-regulation failure-to-warn fifra-preemption product-liability state-law warning-requirements |
Whether FIFRA preempts a state-law failure-to-warn claim where EPA has repeatedly concluded that the warning is not required and the warning cannot be… |
| 24-1068 |
Monsanto Company v. John L. Durnell |
Missouri |
2025-04-09 |
Granted |
CVSGAmici (6)Relisted (3) |
epa-approval failure-to-warn fifra-preemption pesticide-regulation product-labeling state-law-claim |
Whether FIFRA preempts a state-law failure-to-warn claim where EPA has repeatedly concluded that the warning is not required and the warning cannot be… |
| 24A866 |
Monsanto Company v. Larry Johnson, et al. |
Oregon |
2025-03-11 |
Presumed Complete |
|
express-preemption failure-to-warn FIFRA-preemption glyphosate implied-preemption pesticide-labeling |
Question not identified. |
| 24A720 |
Merck Sharp & Dohme Corporation v. Doris Albrecht, et al. |
Third Circuit |
2025-01-22 |
Presumed Complete |
|
drug-labeling failure-to-warn federal-regulations pharmaceutical-liability preemption product-liability |
Question not identified. |
| 24A89 |
Monsanto Company v. John D. Carson |
Eleventh Circuit |
2024-07-25 |
Presumed Complete |
|
epa-approval failure-to-warn fifra labeling preemption state-law-claims |
Question not identified. |
| 23-196 |
Jade Mound, et al. v. United States |
Eighth Circuit |
2023-09-01 |
Denied |
|
budgetary-considerations circuit-court-conflict circuit-split discretionary-function-exception failure-to-warn federal-tort-claims-act government-liability latent-danger public-safety warning-duty |
When the government is alleged to have tortiously neglected to warn the public of a known, latent danger, whether the de minimis cost of posting such … |
| 21-1272 |
Monsanto Company v. Alberta Pilliod, et al. |
California |
2022-03-21 |
Denied |
Amici (1) |
compensatory-damages due-process epa-regulation failure-to-warn federal-insecticide-fungicide-and-rodenticide-act fifra-preemption preemption product-labeling punitive-damages |
1. Whether FIFRA preempts a state-law failure-to-warn claim where the warning cannot be added to a product without EPA approval and EPA has repeatedly… |
| 21-1238 |
Ina Ann Rodman v. Otsuka America Pharmaceutical, Inc. |
Ninth Circuit |
2022-03-11 |
Denied |
Response Waived |
21-cfr-314-80 design-defect drug-labeling expert-testimony failure-to-warn misbranding pharmaceutical-liability post-marketing-surveillance summary-judgment wyeth-v-levine |
1. Whether Ms. Rodman presented admissible evidence in the form of Otsuka's failure to follow the admonition of 21 C.F.R. § 314.80 to conduct post-mar… |
| 21-1144 |
Tracie Leach, et al. v. Mentor Worldwide, LLC |
Ninth Circuit |
2022-02-17 |
Denied |
Response WaivedRelisted (2) |
adverse-events defective-manufacture failure-to-warn food-drug-cosmetic-act medical-device-amendments preemption rule-12(b)(6) state-common-law |
The question presented is whether preemption
under the Medical Device Amendments to the Food,
Drug, and Cosmetic Act supports Rule 12(b)(6)
dismiss… |
| 21-590 |
A. Michael Davallou v. United States |
First Circuit |
2021-10-22 |
Denied |
Response Waived |
administrative-law discretionary-function-exception failure-to-warn federal-tort-claims-act government-liability hazard-disclosure negligence policy-decision specific-known-immediate-hazard warning-duty |
Whether the Government's failure to warn of a specific, known, immediate hazard, for which the acting agency is responsible, is not the kind of broade… |
| 21-241 |
Monsanto Company v. Edwin Hardeman |
Ninth Circuit |
2021-08-18 |
Denied |
CVSGAmici (8)Response RequestedResponse WaivedRelisted (4) |
daubert-standard epa-approval expert-testimony failure-to-warn federal-insecticide-fungicide-and-rodenticide-act fifra-preemption herbicide-regulation preemption state-law-claims |
1. Whether FIFRA preempts a state-law failure-to-warn claim where the warning cannot be added to a product without EPA approval and EPA has repeatedly… |
| 21-26 |
Brittany Billetts, et al. v. Mentor Worldwide LLC |
Ninth Circuit |
2021-07-09 |
Denied |
|
adverse-events common-law-claims defective-manufacture failure-to-warn food-and-drug-administration medical-device-amendments medical-device-manufacturing preemption rule-12(b)(6) |
The question presented is whether preemption under the Medical Device Amendments to the Food, Drug, and Cosmetic Act supports Rule 12(b)(6) dismissal … |
| 20-1822 |
Amber Brooks, et al. v. Mentor Worldwide LLC |
Tenth Circuit |
2021-07-01 |
Denied |
|
adverse-events defective-manufacture failure-to-warn food-drug-cosmetic-act medical-device-amendments medical-device-manufacturing preemption rule-12(b)(6) state-common-law |
The question presented is whether preemption
under the Medical Device Amendments to the Food,
Drug, and Cosmetic Act supports Rule 12(b)(6) dismissal … |
| 19-8689 |
Rebeca Lawrence v. Medtronic |
Ninth Circuit |
2020-06-12 |
Denied |
Response WaivedIFP |
adverse-events failure-to-warn fda-reporting fda-requirements fraud fraud-allegations medical-device pre-market-approval preemption product-liability reliance |
1. What is the scope of the FDA's requirements of reporting of adverse events and whether Title 21 §803.50; Title 21 §803.56; and Title 21 §814.84 exp… |
| 19-1246 |
Rita McDaniel, Individually and as Personal Representative of the Estate of Johnny F. McDaniel, Deceased v. Upsher-Smith Laboratories, Inc. |
Sixth Circuit |
2020-04-26 |
Denied |
|
failure-to-warn fda-labeling fda-regulations federal-regulations implied-preemption medication-guide parallel-federal-regulations preemption state-law tort-claim |
Whether a state-law, failure-to-warn claim that parallels a defendant's failure to follow FDA labeling regulations is impliedly preempted? |
| 19-192 |
Matthew Herrick v. Grindr LLC, et al. |
Second Circuit |
2019-08-14 |
Denied |
Response Waived |
affirmative-defense communications-decency-act failure-to-warn fraud interactive-computer-services motion-to-dismiss negligence non-publication-torts product-liability publication-torts section-230 |
(1) Does the Communications Decency Act § 230(c)(1), which protects interactive computer services from liability for traditional publication torts whe… |